Phase 2 Lung Cancer Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who are willing and able to sign a consent form agreeing to take part in the trial.
- People who are 18 years of age or older.
- People who have been diagnosed with small cell lung cancer (SCLC) through a tissue or cell sample, and whose cancer is either at an advanced (extensive) stage, has come back after previous treatment, or returned more than six months after completing a curative treatment course — confirmed by imaging scans.
- People whose general health and ability to carry out daily activities is rated at 0 or 1 on a standard scale used by doctors (meaning fully active or able to carry out light activity).
- People who are expected to live for at least 12 weeks.
- People who have at least one measurable area of cancer visible on scans, based on standard measurement guidelines (called RECIST 1.1).
- People whose liver, kidneys, blood, and other major organs are functioning well enough to meet the trial's requirements.
- Women who could become pregnant must agree to use effective contraception from the start of the trial until at least 30 days after it ends, and must have a negative pregnancy test (urine or blood) within 7 days before joining.
- Men who have not been surgically sterilised must agree to use effective contraception throughout the trial and for at least 30 days after it ends.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who have had a different type of cancer (other than SCLC) within the past five years.
- People with any unstable ongoing medical condition, such as uncontrolled high blood pressure or a serious irregular heartbeat.
- People who have an active or suspected autoimmune disease, or an autoimmune condition related to cancer, that requires treatment affecting the whole body.
- People who are known to be allergic to the trial drug or any of its ingredients.
- People with active hepatitis B, hepatitis C, or HIV infection.
- People who currently have interstitial lung disease (a condition causing scarring or inflammation in the lungs).
- Women who are pregnant or currently breastfeeding.
- People who have any condition that affects the body's ability to absorb food or medication properly.
- People with neurological or mental health conditions that would prevent them from cooperating with the trial requirements.
- People whom the trial researchers consider unsuitable for participation for any other reason.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Progression-free survival (PFS)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.